Rev Esp Quimioter 2023;36(Suppl.1):18-21

Therapeutic strategy in the transplanted patients

MARIA JOSÉ NÚÑEZ-ORANTOS, AGUSTÍN JULIÁN-JIMÉNEZ, FRANCISCO JAVIER CANDEL, JUAN GONZÁLEZ DEL CASTILLO

Published: 24 November 2023

http://www.doi.org/10.37201/req/s01.05.2023

ABSTRACT
The SARS-CoV-2 infection prognosis has dramatically changed as a result of population vaccination and the surge of omicron. However, there are still specific populations at risk of progression to severe diseases that require hospitalization or even at risk of death. The kidney transplant population is one of them. Consequently, when compatible symptoms appear, an early diagnosis should be sought in order to start specific antiviral treatment as soon as possible to avoid clinical deterioration of the patient. Antivirals have shown, in transplant patients, a decrease in the rate of hospitalization and death, especially with their early administration.

Rev Esp Quimioter 2023; 36(Suppl.1):18-21 [Full-text PDF]